PAX8 Blocking Peptide for STJ502166 peptide (STJ504542)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 225-275 on human PAX8 protein.
General Information
| Short Description | PAX8 Blocking Peptide for STJ502166 is synthetically produced from the 225-275 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 225-275 on human PAX8 protein. |
| Immunogen Region | 225-275 |
| Specificity | This blocking peptide is recommended for use in combination with PAX8 antibody, STJ502166 |
Additional Info
| Background | Is a transcription factor for the thyroid specific expression of the genes expressed solely in the thyroid cell type.ย It maintains the funcitonal differentiation of cells such as those. |
Information sourced from Uniprot.org